Monroe Capital Income Plus issues 1.17M shares at $9.77 (NAV), declares $0.071/share distribution

Monroe Capital Income Plus Corp

Issued 1,174,995 shares of common stock at $9.77 per share for aggregate proceeds of $11.48M.
Sale exempt from registration under Section 4(a)(2) and Regulation D/S.
Board declared a distribution of $0.071 per share payable on May 27, 2026 to holders of record May 21, 2026.
Net asset value per share as of April 30, 2026 is $9.77.

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001742313-26-000028
form_type: 8-K
ticker: null
cik: 0001742313
company_name: Monroe Capital Income Plus Corp
filed_at: 2026-05-21T20:41:06+00:00
discovered_at: 2026-05-21T20:42:01.256577+00:00
generated_at: 2026-05-21T20:43:17.259171+00:00
sec_items: ["3.02", "8.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001742313-26-000028
json_url: https://secwatch.observer/filing/0001742313-26-000028.json
markdown_url: https://secwatch.observer/filing/0001742313-26-000028.md
text_url: https://secwatch.observer/filing/0001742313-26-000028.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1742313/000174231326000028/0001742313-26-000028-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1742313/000174231326000028/mcip-20260521.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

Lord Abbett Private Credit Fund S declares $0.19/sh distribution, NAV $24.70

Lord Abbett Private Credit Fund S May 29, 2026, 1:48 PM ET other_material Items 3.02, 7.01, 8.01

same SEC item: 3.02, 8.01 same event type: other_material similar materiality

Lord Abbett Private Credit Fund reports NAV $24.78, declares $0.22 distribution; issues 379,963 shares at $24.78

Lord Abbett Private Credit Fund May 29, 2026, 1:46 PM ET other_material Items 3.02, 7.01, 8.01

same SEC item: 3.02, 8.01 same event type: other_material similar materiality

Spyre Therapeutics expands SPY003 license field beyond IBD with dosing restrictions until 2028-2030

Spyre Therapeutics, Inc. June 1, 2026, 4:01 PM ET other_material Items 8.01, 9.01